Kanso Diagnostics

Molecular Testing Platform

Startup

Kanso Diagnostics is a Or Yehuda-based startup in the Health Tech & Life Sciences sector, established in 2022. Molecular Testing Platform. The company has raised a total of $1.5M across 3 funding rounds, currently at the Seed stage. Kanso Diagnostics was founded by Roy Rabinowitz and Omer Stoller. The company has 1-10 employees. Core technologies: Biologicals, Microorganisms, Genes, Molecules.

With $1.5M in total funding, Kanso Diagnostics is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B2C/B2B business model. Product stage: Alpha. The company holds 1 patent.

$1.5M
Raised
3
Rounds
2
Investors
4
Team
2022
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesMedical DevicesAssistive DevicesDiagnostics DevicesBiologicalsMicroorganismsGenesMolecules
At a Glance
Founders
In the News

3 articles covered by sources including www.haaretz.com, www.themarker.com, online.fliphtml5.com.

www.haaretz.com · Jan 18, 2025
Kanso Diagnostics: Faster, Simpler, Better
Read article ↗
Frequently Asked Questions
What does Kanso Diagnostics do?

Kanso diagnostics develop a molecular testing platform for diagnosis of bacterial and viral infections. The company's solution aims to change the contemporary diagnostics experience, and the platform facilitates the at-home medical revolution, ensuring accessibility and ease of use. Kanso's novel technology accurately detects multiple pathogens and genetic biomarkers from a single sample, minimizing diagnosis time-to-results from days to minutes. This proprietary technology offers PCR-grade accuracy and rapid home testing convenience, providing an end-to-end solution for diagnosing bacterial and viral infections, available anywhere and anytime.

How much funding has Kanso Diagnostics raised?

Kanso Diagnostics has raised $1.5M in total funding across 3 rounds. The company is currently at the Seed stage.

Who founded Kanso Diagnostics?

Kanso Diagnostics was founded in 2022 by Roy Rabinowitz (Co-founder & CEO), Omer Stoller (Co-founder & CTO).

What sector is Kanso Diagnostics in?

Kanso Diagnostics operates in Health Tech & Life Sciences, Medical Devices, Assistive Devices, Diagnostics Devices, with core technologies in Biologicals, Microorganisms, Genes, Molecules. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Insurance Companies, Providers, Medical Devices Industry, Medical Equipment, Life Sciences, Biotechnology.

Where is Kanso Diagnostics located?

Kanso Diagnostics is based in Or Yehuda, Israel, Center District.

View Full Profile Classic View Website ↗